Literature DB >> 19363678

IkBα promoter polymorphisms in patients with ankylosing spondylitis.

Yu-Hung Hung1, Tsan-Teng Ou, Chia-Hui Lin, Ruei-Nian Li, Yu-Chih Lin, Wen-Chan Tsai, Hong-Wen Liu, Jeng-Hsien Yen.   

Abstract

The purpose of this study is to investigate the association of IκBα with the development of ankylosing spondylitis (AS) in Taiwan. One hundred and fifty-four patients with AS and 112 unrelated healthy controls were enrolled in this study. The IκBα-881A/G, -826C/T, -550A/T, -519C/T, and -297C/T polymorphisms were determined by the polymerase chain reaction/restriction fragment length polymorphism method. This study demonstrated that the genotype frequencies of IκBα-826C/T and -826T/T, and allele frequencies of IκBα-826T were significantly higher in the patients with AS than in the controls. We also found that the estimated haplotype frequencies of IκBα-881A -826T -550A -519C -297C and IκBα-881A -826C -550A -519T -297C were significantly increased in the patient with AS in comparison with that of the controls. In contrast, the estimated haplotype frequency of IκBα-881A -826C -550A -519C -297C was significantly decreased in the patients with AS. This study demonstrates that IκBα-826T is associated with the development of AS. Furthermore, the IκBα-881A -826T -550A -519C -297C and IκBα-881A -826C -550A -519T -297C haplotypes are related to susceptibility to AS in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19363678     DOI: 10.1007/s00296-009-0923-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  34 in total

1.  IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis.

Authors:  C-H Lin; T-T Ou; C-C Wu; W-C Tsai; H-W Liu; J-H Yen
Journal:  Int J Immunogenet       Date:  2007-02       Impact factor: 1.466

Review 2.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

Review 3.  Rel/NF-kappa B and I kappa B proteins: an overview.

Authors:  M J May; S Ghosh
Journal:  Semin Cancer Biol       Date:  1997-04       Impact factor: 15.707

4.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.

Authors:  J F Klement; N R Rice; B D Car; S J Abbondanzo; G D Powers; P H Bhatt; C H Chen; C A Rosen; C L Stewart
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

5.  Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis.

Authors:  N Mozzato-Chamay; E L Corbett; R L Bailey; D C Mabey; J Raynes; D J Conway
Journal:  Genes Immun       Date:  2001-05       Impact factor: 2.676

6.  NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis.

Authors:  Susana Castro-Alcaraz; Veronika Miskolci; Bharati Kalasapudi; Dennis Davidson; Ivana Vancurova
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

Review 7.  Breakthroughs in genetic studies of ankylosing spondylitis.

Authors:  M A Brown
Journal:  Rheumatology (Oxford)       Date:  2007-11-22       Impact factor: 7.580

8.  Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.

Authors:  B Miterski; S Böhringer; W Klein; E Sindern; M Haupts; S Schimrigk; J T Epplen
Journal:  Genes Immun       Date:  2002-06       Impact factor: 2.676

9.  IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.

Authors:  Tsan-Teng Ou; Chia-Hui Lin; Yu-Chih Lin; Ruei-Nian Li; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2008-07-04       Impact factor: 8.317

Review 10.  NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.

Authors:  X-F Sun; H Zhang
Journal:  Histol Histopathol       Date:  2007-12       Impact factor: 2.303

View more
  4 in total

1.  Inhibitor IkappaBalpha promoter functional polymorphisms in patients with rheumatoid arthritis.

Authors:  Ruei-Nian Li; Yu-Hung Hung; Chia-Hui Lin; Yen-Hsu Chen; Jen-Hsien Yen
Journal:  J Clin Immunol       Date:  2010-06-19       Impact factor: 8.317

2.  Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.

Authors:  Guo-Long Zhang; Yan-Feng Zou; Xiao-Liang Feng; He-Jian Shi; Xu-Feng Du; Min-Hua Shao; Yong Gu; Qing Zhou
Journal:  Inflamm Res       Date:  2010-05-21       Impact factor: 4.575

3.  Dissecting the Underlying Pharmaceutical Mechanism of Chinese Traditional Medicine Yun-Pi-Yi-Shen-Tong-Du-Tang Acting on Ankylosing Spondylitis through Systems Biology Approaches.

Authors:  Duoli Xie; Lin Huang; Guanghui Zhao; Yiran Yu; Jiawei Gao; Haichang Li; Chengping Wen
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

4.  Integrative Single-Cell RNA-Seq and ATAC-Seq Analysis of Peripheral Mononuclear Cells in Patients With Ankylosing Spondylitis.

Authors:  Huixuan Xu; Haiyan Yu; Lixiong Liu; Hongwei Wu; Cantong Zhang; Wanxia Cai; Xiaoping Hong; Dongzhou Liu; Donge Tang; Yong Dai
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.